Literature DB >> 308953

Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.

P J Fialkow, A M Denman, R J Jacobson, M N Lowenthal.   

Abstract

In three patients with chronic myelocytic leukemia who were heterozygous at the X-linked glucose-6-phospháte dehydrogenase locus, lymphocytes were studied to determine if they had the same stem cell origin as the leukemic myeloid cells. Normal tissues such as skin had both B and A glucose-6-phosphate dehydrogenase isoenzymes, but the leukemic myelogenous cells displayed only one isoenzyme type, consistent with their clonal origin. A population of cells with undoubted thymus-derived (T)-lymphocyte characteristics had both isoenzymes. Presumably, then, these T cells did not arise from the leukemic stem cell, either because they antedated the development of leukemia in that stem cell or, more likely, because they arose from progenitors not involved by the disease. In contrast, another population of lymphocytes showed only one isoenzyme type, suggesting that it arose from the chronic myelocytic leukemia stem cell. However, although this population contained many cells with the characteristics of bone marrow-derived (B) lymphocytes, it is not certain that the single enzyme produced by the cells over all can be attributed to B lymphocytes rather than to contaminating non-B-lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308953      PMCID: PMC371833          DOI: 10.1172/JCI109193

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA.

Authors:  J WHANG; E FREI; J H TJIO; P P CARBONE; G BRECHER
Journal:  Blood       Date:  1963-12       Impact factor: 22.113

2.  DEMONSTRATION OF TWO POPULATIONS OF CELLS IN THE HUMAN FEMALE HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE VARIANTS.

Authors:  R G DAVIDSON; H M NITOWSKY; B CHILDS
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

3.  Cytogenetic studies on bone-marrow in chronic myeloid leukaemia.

Authors:  I M TOUGH; P A JACOBS; W M COURT BROWN; A G BAIKIE; E R WILLIAMSON
Journal:  Lancet       Date:  1963-04-20       Impact factor: 79.321

4.  The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker.

Authors:  E BEUTLER; M YEH; V F FAIRBANKS
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

5.  Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro.

Authors:  E J O'Rourke; S B Halstead; A C Allison; T A Platts-Mills
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

6.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

7.  Rapid identification of monocytes in a mixed mononuclear cell preparation.

Authors:  S B Tucker; R V Pierre; R E Jordon
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia.

Authors:  G Janossy; M Roberts; M F Greaves
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

9.  Antigens expressed by human B lymphocytes and myeloid stem cells.

Authors:  M J Cline; R Billing
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

10.  The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems.

Authors:  S Abramson; R G Miller; R A Phillips
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  38 in total

Review 1.  An evolving model of hematopoietic stem cell functional identity.

Authors:  M William Lensch
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

2.  Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.

Authors:  Marcus Järås; Petra Johnels; Nils Hansen; Helena Agerstam; Panagiotis Tsapogas; Marianne Rissler; Carin Lassen; Tor Olofsson; Ole Weis Bjerrum; Johan Richter; Thoas Fioretos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Not a split decision for human hematopoiesis.

Authors:  Kenneth Dorshkind
Journal:  Nat Immunol       Date:  2010-07       Impact factor: 25.606

Review 4.  Applying the discovery of the Philadelphia chromosome.

Authors:  Daniel W Sherbenou; Brian J Druker
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 6.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

7.  CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report.

Authors:  Irene Dogliotti; Carmen Fava; Anna Serra; Enrico Gottardi; Filomena Daraio; Francesca Carnuccio; Emilia Giugliano; Monica Bocchia; Giuseppe Saglio; Giovanna Rege-Cambrin
Journal:  Stem Cell Investig       Date:  2017-06-23

8.  Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

Authors:  Richard T Williams; Willem den Besten; Charles J Sherr
Journal:  Genes Dev       Date:  2007-08-30       Impact factor: 11.361

9.  Establishment of the DU.528 human lymphohemopoietic stem cell line.

Authors:  J Kurtzberg; S H Bigner; M S Hershfield
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Blast crisis in a murine model of chronic myelogenous leukemia.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.